Tian C,Xiang M*.Therapeutic agents against COVID-19 with clinical evidence.Curr Pharm Des. 2021, Jan 14;27:1-10.doi: 10.2174/1381612827666210114150951. (* correspondence author)
Release time:2022-11-12
Hits:
- Pre One:Li Q,Xiang M*. Metabolic reprograming of MDSCs within tumor microenvironment and targeting for cancer immunotherapy. Acta Pharmacol Sin. 2021 Sep 24. doi: 10.1038/s41401-021-00776-4.
- Next One:Tuo Y, Zhang Z, Tian C, Hu Q, Xie R, Yang J, Zhou H, Lu L,Xiang M*. Anti-inflammatory and metabolic reprogramming effects of MENK produce antitumor response in CT26 tumor-bearing mice. J Leukoc Biol. 2020 Jul;108(1):215-228. doi: 10.1002/JLB.3MA0120-578R.